3 Rivers Biotech To Distribute Elite Hemp Varieties From Trilogene Seeds

3 Rivers Biotech, a plant biotechnology specializing in hemp tissue culture, has entered into a Genetic Distribution and Royalty Agreement with Trilogene Seeds, a preeminent genetics provider.

Trilogene has an extensive reach across the United States, strategic relationships with several universities, and a vast genetic catalog. Under the terms of the agreement, 3 Rivers will initiate, micropropagate and sell some of Trilogene’s premium hemp varieties to licensed growers across the United States. These premium products include both high-CBD varieties bred for large-scale mechanical harvesting, more nuanced varieties with unique terpene profiles for smokable flower products and the next generation of marketable minor cannabinoids, such as CBG and CBC.

For more information, visit www.3riversbiotech.com.